CIK 0001425205 · Accelerated filer
IOVANCE BIOTHERAPEUTICS, INC.
Sign in to watch- Ticker
- IOVA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 753254381
- Phone
- 6502607120
- Business address
- 825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
- Former names
- Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-15 | BILINSKY IGOR Chief Operating Officer | Option exercise | +2,813 | 42,571 | ||
| 2024-07-15 | BILINSKY IGOR Chief Operating Officer | Shares withheld for taxes | −1,428 | $8.68 | $12K | 41,143 |
| 2024-07-15 | BILINSKY IGOR Chief Operating Officer | Option exercise · Restricted Stock Units | −2,813 | 5,626 | ||
| 2024-06-11 | Countouriotis Athena Director | Grant or award · Deferred Restricted Stock Unit | +49,303 | 49,303 | ||
| 2024-06-11 | YARNO WENDY L Director | Grant or award · Deferred Restricted Stock Unit | +49,303 | 49,303 | ||
| 2024-06-11 | WEISER MICHAEL Director | Grant or award · Deferred Restricted Stock Unit | +49,303 | 49,303 | ||
| 2024-06-11 | Maynard Ryan D Director | Grant or award · Deferred Restricted Stock Unit | +49,303 | 49,303 | ||
| 2024-06-11 | Dukes Iain D. Director | Grant or award · Deferred Restricted Stock Unit | +98,607 | 98,607 | ||
| 2024-06-03 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise | +3,906 | 46,468 | ||
| 2024-06-03 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Shares withheld for taxes | −1,982 | $8.37 | $17K | 44,486 |
| 2024-06-03 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise · Restricted Stock Units | −3,906 | 27,346 | ||
| 2024-06-03 | BILINSKY IGOR Chief Operating Officer | Option exercise | +3,516 | 41,542 | ||
| 2024-06-03 | BILINSKY IGOR Chief Operating Officer | Shares withheld for taxes | −1,784 | $8.37 | $15K | 39,758 |
| 2024-06-03 | BILINSKY IGOR Chief Operating Officer | Option exercise · Restricted Stock Units | −3,516 | 24,613 | ||
| 2024-06-03 | Vogt Frederick G Interim CEO & General Counsel | Option exercise | +10,417 | 151,751 | ||
| 2024-06-03 | Vogt Frederick G Interim CEO & General Counsel | Shares withheld for taxes | −4,426 | $8.37 | $37K | 147,325 |
| 2024-06-03 | Vogt Frederick G Interim CEO & General Counsel | Option exercise · Restricted Stock Units | −10,417 | 72,921 | ||
| 2024-04-15 | Vogt Frederick G Interim CEO & General Counsel | Option exercise | +20,834 | 150,185 | ||
| 2024-04-15 | Vogt Frederick G Interim CEO & General Counsel | Shares withheld for taxes | −8,851 | $11.89 | $105K | 141,334 |
| 2024-04-15 | Vogt Frederick G Interim CEO & General Counsel | Option exercise · Restricted Stock Units | −20,834 | 62,504 |
Page 14 of 14 · 280 trades